A clinical trial to study the efficacy of local anesthetic drug bupivacaine injected at the site of instrument entry in the abdomen during laparoscopic sterilization in females

To compare the efficacy of intra-peritoneal instillation along with local infiltration with Bupivacaine versus placebo for post-operative analgesia after laparoscopic tubal ligation

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/10/015982

Enrollment

Registered

2018-10-10

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 3- Administration

Interventions

Intervention1: Bupivacaine: Dose of Bupivacaine: 0.25mg/Kg Concentration used: 0.25%. Frequency: One time infiltration and instillation Total Dosage: 20 ml of 0.25% bupivacaine to be instilled into t

Eligibility

Inclusion criteria

Inclusion criteria: all women who present for laparoscopic tubal ligation

Exclusion criteria

Exclusion criteria: any intra-operative complication like hematoma formation avulsion of Fallopian tube any allergy to used drug

Design outcomes

Primary

Measure	Time frame
Outcome name: Post operative pain relief. Pain to be assessed by visual analogue score [VAS]Timepoint: Time point: One hourly post operative for 6 hours	—

Secondary

Measure	Time frame
Outcome Name: Side effects of drugs if anyTimepoint: Time Points: every one hour for 24 hours	—

Countries

India

Contacts

Public ContactDr Aniket Kakade

Bharati Vidyapeeth [Deemed to be University] Medical College, Pune

aniket1kakade@gmail.com02045555555

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026